Sourced article: 20 Medical Studies That Prove Cannabis Can

New Post Public Reply Private Reply Replies (1) Message Board
bellsandwhistles
Sourced article: 20 Medical Studies That Prove Cannabis Can Cure Cancer

August 23, 2013 by Arjun Walia
arjun@collective-evolution.com

Cannabis has been making a lot of noise lately. Multiple states across the United States and countries around the world have successfully legalized medical Marijuana, and the Uruguay parliament recently voted to create the world’s first legal marijuana market. This is good news as the health benefits of Cannabis are vast, with multiple medical and scientific studies that confirm them. On the other hand, arguments against the use of marijuana is usually published in Psychiatric journals, which show no scientific evidence that Cannabis is harmful to human health. All psychological evaluations from the intake of cannabis are largely based on assumptions, suggestions and observations (1). When we look at the actual science behind Cannabis, the health benefits can be overwhelming. So what does one who opposes the use of cannabis base their belief on? Nothing, not scientific evidence anyways. The negative stigmatism attached to marijuana is due to it’s supposed psychotropic effects, yet again, there is no scientific evidence to show that marijuana has any psychotropic effects. Nonetheless, cannabis has recently been the focus of medical research and considered as a potential therapeutic treatment and cure for cancer.

Cannabis is a great example of how the human mind is programmed and conditioned to believe something. Growing up, we are told drugs are bad, which is very true, however not all substances that have been labelled as “drugs” by the government are harmful. Multiple substances are labelled as a “drug” in order to protect corporate interests. One example is the automobile and energy industry, a car made from hemp is stronger than steel, and can be fuelled from hemp alone. Henry Ford demonstrated this many years ago. Hemp actually has over 50,000 uses!

Let’s take a look at the science behind Cannabis and Cancer. Although Cannabis has been proven to be effective for a large range of ailments, this article will focus mainly on it’s effectiveness in the treatment of cancer. Cannabinoids may very well be one of the best disease and cancer fighting treatments out there. Cannabinoids refer to any of a group of related compounds that include cannabinol and the active constituents of cannabis. They activate cannabinoid receptors in the body. The body itself produces compounds called endocannabinoids and they play a role in many processes within the body that help to create a healthy environment. Cannabinoids also play a role in immune system generation and re-generation. The body regenerates best when it’s saturated with Phyto-Cannabinoids. Cannabinoids can also be found in Cannabis. It is important to note that the cannabinoids are plentiful in both hemp and cannabis. One of the main differentiations between hemp and cannabis is simply that hemp only contains 0.3% THC while cannabis is 0.4% THC or higher. (Technically they are both strains of Cannabis Sativa.)  Cannabinoids have been proven to reduce cancer cells as they have a great impact on the rebuilding of the immune system. While not every strain of cannabis has the same effect, more and more patients are seeing success in cancer reduction in a short period of time by using cannabis.

While taking a look at these studies, keep in mind that cannabis can be much more effective for medicinal purposes when we eat it rather than smoking it. Below are 20 medical studies that prove cannabis can be an effective treatment and possible cure for cancer. Please keep in mind that this is a very short list of studies that support the use of medicinal marijuana. Please feel free to further your research, hopefully this is a good starting point.

Brain Cancer

1.  A study published in the British Journal of Cancer , conducted by the Department of Biochemistry and Molecular Biology at Complutense University in Madrid, this study determined that Tetrahydrocannabinol (THC) and other cannabinoids inhibit tumour growth. They were responsible for the first clinical study aimed at assessing cannabinoid antitumoral action. Cannabinoid delivery was safe and was achieved with zero psychoactive effects. THC was found to decrease tumour cells in two out of the nine patients.

2. A study published in The Journal of Neuroscience examined the biochemical events in both acute neuronal damage and in slowly progressive, neurodegenerative diseases. They conducted a magnetic resonance imaging study that looked at THC (the main active compound in marijuana) and found that it reduced neuronal injury in rats. The results of this study provide evidence that the cannabinoid system can serve to protect the brain against neurodegeneration.

3. A study published in The Journal of Pharmacology And Experimental Therapeutics already acknowledged the fact that cannabinoids have been shown to possess antitumor properties. This study examined the effect of cannabidiol (CBD, non psychoactive cannabinoid compound) on human glioma cell lines. The addition of cannabidiol led to a dramatic drop in the viability of glioma cells. Glioma is the word used to describe brain tumour.  The study concluded that cannabidiol was able to produce a significant antitumor activity.

4. A study published in the journal Molecular Cancer Therapeutics outlines how brain tumours are highly resistant to current anticancer treatments, which makes it crucial to find new therapeutic strategies aimed at improving the poor prognosis of patients suffering from this disease. This study also demonstrated the reversal of tumour activity in Glioblastoma multiforme.

Breast Cancer

5. A study published in the US National Library of Medicine , conducted by the California Pacific Medical Centre determined that cannabidiol (CBD) inhibits human breast cancer cell proliferation and invasion. They also demonstrated that CBD significantly reduces tumour mass.

6. A study published in The Journal of Pharmacology and Experimental Therapeutics determined that THC as well as cannabidiol dramatically reduced breast cancer cell growth. They confirmed the potency and effectiveness of these compounds.

7. A study published in the Journal Molecular Cancer showed that THC reduced tumour growth and tumour numbers. They determined that cannabinoids inhibit cancer cell proliferation, induce cancer cell apoptosis and impair tumour angiogenesis (all good things). This study provides strong evidence for the use of cannabinoid based therapies for the management of breast cancer.

8. A study published in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) determined that cannabinoids inhibit human breast cancer cell proliferation.

Lung Cancer

9. A study published in the journal Oncogene , by Harvard Medical Schools Experimental Medicine Department determined that THC inhibits epithelial growth factor induced lung cancer cell migration and more. They go on to state that THC should be explored as novel therapeutic molecules in controlling the growth and metastasis of certain lung cancers.

10. A study published by the US National Library of Medicine by the Institute of Toxicology and Pharmacology , from the Department of General Surgery in Germany determined that cannabinoids inhibit cancer cell invasion. Effects were confirmed in primary tumour cells from a lung cancer patient.  Overall, data indicated that cannabinoids decrease cancer cell invasiveness.

11. A study published by the US National Library of Medicine, conducted by Harvard Medical School investigated the role of cannabinoid receptors in lung cancer cells. They determined its effectiveness and suggested that it should be used for treatment against lung cancer cells.

Prostate Cancer

12. A study published in the US National Library of Medicine illustrates a decrease in prostatic cancer cells by acting through cannabinoid receptors.

13. A study published in the US National Library of Medicine outlined multiple studies proving the effectiveness of cannabis on prostate cancer.

14. Another study published by the US National Library of Medicine determined that clinical testing of CBD against prostate carcinoma is a must. That cannabinoid receptor activation induces prostate carcinoma cell apoptosis. They determined that cannabidiol significantly inhibited cell viability.
Blood Cancer

15. A study published in the journal Molecular Pharmacology recently showed that cannabinoids induce growth inhibition and apoptosis in matle cell lymphoma. The study was supported by grants from the Swedish Cancer Society, The Swedish Research Council and the Cancer Society in Stockholm.

16. A study published in the International Journal of Cancer also determined and illustrated that cannabinoids exert antiproliferative and proapoptotic effects in various types of cancer and in mantle cell lymphoma.

17. A study published in the US National Library of Medicine conducted by the Department of Pharmacology and Toxicology by Virginia Commonwealth University determined that cannabinoids induce apoptosis in leukemia cells.

Oral Cancer

18. A study published by the US National Library of Medicine results show cannabinoids are potent inhibitors of cellular respiration and are toxic to highly malignant oral Tumours.
Liver Cancer

19. A study published by the US National Library of Medicine determined that that THC reduces the viability of human HCC cell lines (Human hepatocellular liver carcinoma cell line) and reduced the growth.

Pancreatic Cancer

20. A study published in The American Journal of Cancer determined that cannabinoid receptors are expressed in human pancreatic tumor cell lines and tumour biopsies at much higher levels than in normal pancreatic tissue. Results showed that cannabinoid administration induced apoptosis. They also reduced the growth of tumour cells, and inhibited the spreading of pancreatic tumour cells.

Sources:

All sources highlighted throughout article. Click on the highlighted parts of the article to view them.

1) http://bjp.rcpsych.org/content/178/2/116.full

About the author

Arjun Walia

I've been researching into many of the topics I write about for several years, a few of my interests stem from childhood. A combination of research and life experiences have led me down the journey I find myself on today. I've always questioned the world around me, and have had a deep desire to change the world the best way I know how. If you'd like to know more about me, my life experiences, education, or anything else, feel free to email me.  arjun@collective-evolution.com


SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Skyven's Heat Pump Sets New Steam Efficiency Benchmark

Updated Category News Views 3

The Efficiency Game-Changer in Industrial Steam Swinging in like a seasoned market shake-up is Skyven Technologies, raising eyebrows—and interest—by nailing a coefficient of performance (COP) of 8.0 for their Arcturus heat pump. You don't have to be a market wizard to know that's a big leap from the initial COP of 6.5. It's more than just numbers on a page; this...

Continue Reading
Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

Updated Category News Views 0

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Continue Reading
Geek+ Spurs Growth with 35.5% Order Surge and New Model

Updated Category News Views 2

Unexpected Surge in Orders Drives Geek+ It looks like Geek+ isn't just playing around in the robotics sandbox anymore. They're delivering some serious results, reporting a 35.5% increase in new signed orders reaching a whopping RMB2.385 billion for the first half of 2026. That's not chump change, and it injects a healthy dose of optimism into their future performance...

Continue Reading
Art Ave Spurs Rebirth in Downtown DC: A Template for Revival

Updated Category News Views 0

Turning Streets into Art Galleries No one would have believed a stretch of DC's bureaucratic offices was about to morph into a vibrant destination worthy of major art aficionados. But here we are, tipping our hats to the Golden Triangle Business Improvement District (BID), who just snagged the IDA Downtown Achievement Award of Excellence for their Art Ave project. Not...

Continue Reading
PMI Foods Fuels Hunger Action Month with New Partnership

Updated Category News Views 2

Helping Families Put Food on the Table Out there in Utah's schoolyards, Parker Migliorini International (PMI Foods) is taking a tangible step against hunger, whipping out a $15,000 check to back the Utah Food Bank’s Mobile School Pantry initiative. This partnership kicks off in September, aligning with Hunger Action Month, a period dedicated to spotlighting food...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
California's Annual Recovery Happens Event Unites Community

Updated Category News Views 2

A Public Campaign for Recovery Awareness Anyone with a pulse on what's going on in the addiction recovery landscape knows the significance of events like Recovery Happens. It's not just another day in Sacramento; it's a rallying cry for change—a public affirmation that recovery is tangible and thriving. This isn't about showy gala dinners or fancy corporate events; it's...

Continue Reading
Wahl's Bold Move: The Baldscaper™ Revolution

Updated Category News Views 2

A Legacy of Grooming Innovation When Wahl, a brand that's been in the grooming game for over a century, decides to go all in on a new product, you better believe it's worth a look. Wahl's new Baldscaper™ isn't just another gadget in the grooming aisle—it's a statement. Going bald can be a bold choice, and with their latest unveil, Wahl seems to be rewarding every...

Continue Reading
Common Threads Takes Nutrition Education Digital in 2026

Updated Category News Views 4

Digitizing 23 Years of Nutrition Know-How Common Threads has been in the trenches for over two decades, teaching kids and families how to eat right and cook healthier meals. Now, the nonprofit's dragging its vast experience into the digital realm, rolling out a beefed-up version of its TEACH platform this September 15th. Through new certificate courses in Nutrition...

Continue Reading
York Space Systems Faces Class Action After IPO Issues

Updated Category News Views 1

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Tech Sector Gains Momentum as Market Reacts to Rate Cuts

Updated Category News Views 63

Market Overview: Modest Gains and Trader Optimism As the week kicks off, U.S. index futures are showing slight upticks, signaling that traders remain hopeful despite waning enthusiasm from the recent rate cuts. There's a growing expectation that the technology sector will support the market, especially with recent developments involving Intel Corp (NASDAQ: INTC)....

Continue Reading
BDA Strengthens Portfolio with Acquisition of Harper + Scott

Updated Category News Views 944

BDA Strengthens Portfolio with Acquisition of Harper + Scott Deal Grows BDA's Roster of Enterprise Customers, Unites Top Branded Merchandise Agencies Bensussen Deutsch & Associates, LLC (BDA), the nation's leading Merchandise Agency™ for iconic brands including Major League Baseball, Johnson & Johnson, and The Home Depot, has acquired Harper + Scott, a creative branded...

Continue Reading
Mexco Energy Corporation Achieves Growth Amid Oil Price Challenges

Updated Category News Views 170

Mexco Energy Corporation Reports Impressive Financial Performance Mexco Energy Corporation (NYSE American: MXC), based in Midland, Texas, has reported notable financial results for the recently concluded six-month period. The company has achieved a net income of $565,457, translating to $0.27 per diluted share for the interim period ending September 30. Operating Revenues...

Continue Reading
Exciting Developments in (Z)-Endoxifen Research at SABCS 2025

Updated Category News Views 167

Atossa Therapeutics' Bold Moves in Breast Cancer Treatment Atossa Therapeutics, Inc. (NASDAQ: ATOS) is making waves in the oncology sector, focusing on innovative therapies for breast cancer. The company has recently announced that four abstracts on (Z)-endoxifen have been accepted for presentation at the renowned San Antonio Breast Cancer Symposium (SABCS), scheduled for...

Continue Reading
JPMorgan Global Growth & Income Adds New Ordinary Shares

Updated Category News Views 202

JPMorgan Global Growth & Income Expands Share Capital Recently, JPMorgan Global Growth & Income Plc took an important step by issuing 100,000 new Ordinary Shares priced at 581.70 pence each. This decision to issue additional shares aligns with the company’s ongoing strategy to enhance its operational capacity and foster growth. Impact on Share Capital This issuance has...

Continue Reading